Capecitabine and Gemcitabine help battle pancreatic cancer
3rd Nov 2005, 17:04 GMT
The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. Data presented at the 13th European Conference (ECCO) revealed that using the combination of gemcitabine and capecitabine increased overall survival in some patients.
Capecitabine and Gemcitabine help battle pancreatic cancer related news:
- Gemcitabine and capecitabine improved overall survival in patients with advanced pancreatic cancer — EurekAlert! - Breaking News
- ECCO: Xeloda-Gemzar Duo Extends Pancreatic Cancer Survival — MedPage Today.com Latest Headlines
- FDA Approves Tarceva in Combination with Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer — Partnerships/ Joint Ventures News from StratCenter.com
- Tarceva gets FDA go-ahead for pancreatic cancer treatment — The Earth Times Online Newspaper
- Tarceva Approved for Pancreatic Cancer — TheStreet.com
- New chemo combo means longer life for pancreatic cancer patients — News-Medical News Feed
- Lung cancer drug approved for treating pancreatic cancer — News-Medical News Feed
- Multimedia News Release -- FDA Approves Tarceva(R) in Combination With Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer — PR Newswire: All Releases
- Drug can increase pancreatic cancer survival — MSNBC.com: Health
- New treatment for pancreatic cancer — the Mail online | Health news
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info